Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Peptide Manufacturing: Rethinking the Technology Platform for Large Scale Demand - Polypeptide

Peptide Manufacturing: Rethinking the Technology Platform for Large Scale Demand Presented at TIDES Europe, November 13, 2024 Speaker: Jan Pawlas, Scientist Global Development Abstract: The peptide market is strongly impacted by the evolution of the developmen

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Peptide Manufacturing: Rethinking the Technology Platform for Large Scale Demand

Presented at TIDES Europe, November 13, 2024

Speaker: Jan Pawlas, Scientist Global Development

Abstract: The peptide market is strongly impacted by the evolution of the development pipeline, in particular for the treatments that require massive volumes of drugs, driven by the booming demand for metabolic diseases. The scale-up of the existing technology platform to produce synthetic peptides is a major challenge to reach the expected volumes. The current manufacturing technology platform needs to evolve in order to deliver both sustainable and cost-effective solutions. PolyPeptide is a leading CDMO organization, with the capabilities to efficiently adapt to the emerging requirements and to deliver the most effective and sustainable solutions to develop and manufacture your peptides.

Related posts

PolyPeptide showcases leadership in sustainable peptide manufacturing with two landmark publications

PolyPeptide’s Approach to Process Intensification: Tackling the increasing Peptide Demand

Backbone Protecting Groups for Enhanced Peptide and Protein Synthesis

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

comparison

Certified Synthesis vs Uncontrolled Production

The differences between cGMP peptide manufacturing and uncontrolled production are significant and measurable. The table below summarizes the key practical contrasts at the research-supply …

Source: pspeptides.com
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →